Hamilton Point Investment Advisors, LLC Amgen Inc Transaction History

Hamilton Point Investment Advisors, LLC

  • $546 Million
  • Q1 2025

A detailed history of Hamilton Point Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Hamilton Point Investment Advisors, LLC holds 35,010 shares of AMGN stock, worth $9.78 Million. This represents 2.0% of its overall portfolio holdings.

Number of Shares
35,010
Previous 35,214 0.58%
Holding current value
$9.78 Million
Previous $9.18 Million 18.84%
% of portfolio
2.0%
Previous 1.65%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025
SELL
$258.59 - $327.36 $52,752 - $66,781
-204 Reduced 0.58%
35,010 $10.9 Million
Q4 2024

Jan 23, 2025
BUY
$258.78 - $328.31 $137,670 - $174,660
532 Added 1.53%
35,214 $9.18 Million
Q3 2024

Nov 12, 2024
BUY
$309.38 - $337.38 $111,067 - $121,119
359 Added 1.05%
34,682 $11.2 Million
Q2 2024

Aug 06, 2024
BUY
$262.75 - $319.31 $86,182 - $104,733
328 Added 0.96%
34,323 $10.7 Million
Q1 2024

May 07, 2024
SELL
$268.87 - $324.56 $335,818 - $405,375
-1,249 Reduced 3.54%
33,995 $9.67 Million
Q4 2023

Jan 30, 2024
BUY
$255.7 - $288.46 $134,498 - $151,729
526 Added 1.52%
35,244 $10.2 Million
Q3 2023

Nov 09, 2023
SELL
$218.65 - $271.46 $65,813 - $81,709
-301 Reduced 0.86%
34,718 $9.33 Million
Q2 2023

Aug 03, 2023
SELL
$214.27 - $253.37 $84,422 - $99,827
-394 Reduced 1.11%
35,019 $7.77 Million
Q1 2023

May 10, 2023
BUY
$225.79 - $275.2 $309,558 - $377,299
1,371 Added 4.03%
35,413 $8.56 Million
Q4 2022

Jan 30, 2023
BUY
$229.03 - $291.01 $31,148 - $39,577
136 Added 0.4%
34,042 $8.94 Million
Q3 2022

Nov 08, 2022
BUY
$224.46 - $253.15 $164,304 - $185,305
732 Added 2.21%
33,906 $7.64 Million
Q2 2022

Jul 26, 2022
BUY
$230.71 - $256.74 $171,878 - $191,271
745 Added 2.3%
33,174 $8.07 Million
Q1 2022

May 12, 2022
BUY
$219.27 - $242.57 $196,027 - $216,857
894 Added 2.83%
32,429 $7.84 Million
Q4 2021

Feb 07, 2022
BUY
$198.88 - $227.6 $179,389 - $205,295
902 Added 2.94%
31,535 $7.09 Million
Q3 2021

Oct 26, 2021
BUY
$212.27 - $248.7 $66,440 - $77,843
313 Added 1.03%
30,633 $6.51 Million
Q2 2021

Aug 02, 2021
BUY
$233.58 - $259.14 $68,438 - $75,928
293 Added 0.98%
30,320 $7.39 Million
Q1 2021

May 11, 2021
BUY
$221.91 - $258.6 $126,932 - $147,919
572 Added 1.94%
30,027 $7.47 Million
Q4 2020

Feb 04, 2021
BUY
$216.38 - $257.67 $6,058 - $7,214
28 Added 0.1%
29,455 $6.77 Million
Q3 2020

Nov 03, 2020
BUY
$234.65 - $260.95 $202,737 - $225,460
864 Added 3.02%
29,427 $7.48 Million
Q2 2020

Aug 03, 2020
BUY
$197.81 - $242.74 $108,597 - $133,264
549 Added 1.96%
28,563 $6.74 Million
Q1 2020

May 11, 2020
BUY
$182.24 - $241.7 $241,103 - $319,769
1,323 Added 4.96%
28,014 $5.68 Million
Q4 2019

Feb 05, 2020
SELL
$189.21 - $243.2 $3,594 - $4,620
-19 Reduced 0.07%
26,691 $6.43 Million
Q3 2019

Nov 13, 2019
BUY
$174.11 - $208.62 $109,863 - $131,639
631 Added 2.42%
26,710 $5.17 Million
Q2 2019

Jul 18, 2019
BUY
$166.7 - $195.41 $41,174 - $48,266
247 Added 0.96%
26,079 $4.81 Million
Q1 2019

May 03, 2019
BUY
$180.87 - $203.88 $64,570 - $72,785
357 Added 1.4%
25,832 $4.91 Million
Q4 2018

Feb 04, 2019
BUY
$178.4 - $208.25 $235,309 - $274,681
1,319 Added 5.46%
25,475 $4.96 Million
Q3 2018

Oct 29, 2018
BUY
$185.29 - $208.89 $13,711 - $15,457
74 Added 0.31%
24,156 $5.01 Million
Q2 2018

Jul 18, 2018
BUY
$166.05 - $186.51 $91,161 - $102,393
549 Added 2.33%
24,082 $4.45 Million
Q1 2018

May 14, 2018
BUY
$169.43 - $198.0 $4,744 - $5,544
28 Added 0.12%
23,533 $4.01 Million
Q4 2017

Feb 12, 2018
BUY
$168.79 - $188.59 $146,847 - $164,073
870 Added 3.84%
23,505 $4.09 Million
Q3 2017

Nov 13, 2017
BUY
$167.29 - $191.0 $18,401 - $21,010
110 Added 0.49%
22,635 $4.22 Million
Q2 2017

Aug 14, 2017
BUY
N/A
22,525
22,525 $3.88 Million

Others Institutions Holding AMGN

# of Institutions
3,312
Shares Held
429M
Call Options Held
8.06M
Put Options Held
7.7M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hamilton Point Investment Advisors, LLC Portfolio

Follow Hamilton Point Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Point Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Point Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email